# Ezetimibe + Simvastatin

## Vytorin 10/20mg

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OVYT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Indications        | Primary hypercholesterolemia: Adjunctive therapy to diet for the reduction of elevated total-C， LDL-C， Apo B， TG & non-HDL-C， & to increase HDL-C in patients with primary (heterozygous familial & non-familial) hypercholesterolemia or mixed hyperlipidemia. Homozygous familial hypercholesterolemia (HoFH): For the reduction of elevated total-C & LDL-C levels in patients with HoFH， as an adjunct to other lipid-lowering treatments (eg LDL apheresis) or if such treatments are unavailable. |
| Dosing             | Adult: usual dosage range: 10/10 mg/day to 10/40 mg/day. Usual starting dose: 10/10 mg/day or 10/20 mg/day. Take as a single daily dose in the evening， with or without food.                                                                                                                                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Active liver disease or unexplained persistent elevations of serum transaminases. Pregnancy， lactation.                                                                                                                                                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Flatulence， abdominal pain， diarrhea， myalgia， headache， fatigue， thrombocytopenia， hepatitis， increased CPK， elevations of liver transaminases. Gastrointestinal: Diarrhea (2.8% ) Neurologic: Headache (5.8% ) Respiratory: Upper respiratory infection (3.6% )                                                                                                                                                                                                                                   |
| Pregnancy          | Contraindicated – 1st trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

